Wendell Wierenga, PhD

Santarus

Dr Wierenga is EVP R&D at Santarus having formerly held this position at Ambit Biosciences and Neurocrine Biosciences. Formerly CEO Syrrx, Inc. (now Takeda San Diego) and SVP Worldwide Pharmaceutical Sciences, Technologies and Development at Parke-Davis/Warner Lambert (now Pfizer) and research scientist at Upjohn Pharmaceuticals.


Back to overview